- Home
- CHGG vs ATOS Comparison
CHGG vs ATOS Comparison
Compare CHGG & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHGG
- ATOS
- Stock Information
- Founded
- CHGG 2005
- ATOS 2009
- Country
- CHGG United States
- ATOS United States
- Employees
- CHGG N/A
- ATOS N/A
- Industry
- CHGG Other Consumer Services
- ATOS Biotechnology: Pharmaceutical Preparations
- Sector
- CHGG Real Estate
- ATOS Health Care
- Exchange
- CHGG Nasdaq
- ATOS Nasdaq
- Market Cap
- CHGG 169.0M
- ATOS 174.8M
- IPO Year
- CHGG 2013
- ATOS 2012
- Fundamental
- Price
- CHGG $1.52
- ATOS $1.45
- Analyst Decision
- CHGG Hold
- ATOS Strong Buy
- Analyst Count
- CHGG 10
- ATOS 3
- Target Price
- CHGG $5.53
- ATOS $6.25
- AVG Volume (30 Days)
- CHGG 3.9M
- ATOS 507.3K
- Earning Date
- CHGG 11-12-2024
- ATOS 11-12-2024
- Dividend Yield
- CHGG N/A
- ATOS N/A
- EPS Growth
- CHGG N/A
- ATOS N/A
- EPS
- CHGG N/A
- ATOS N/A
- Revenue
- CHGG $683,338,000.00
- ATOS N/A
- Revenue This Year
- CHGG N/A
- ATOS N/A
- Revenue Next Year
- CHGG N/A
- ATOS N/A
- P/E Ratio
- CHGG N/A
- ATOS N/A
- Revenue Growth
- CHGG N/A
- ATOS N/A
- 52 Week Low
- CHGG $1.48
- ATOS $0.62
- 52 Week High
- CHGG $11.48
- ATOS $2.31
- Technical
- Relative Strength Index (RSI)
- CHGG 37.56
- ATOS 52.72
- Support Level
- CHGG $1.48
- ATOS $1.34
- Resistance Level
- CHGG $1.72
- ATOS $1.48
- Average True Range (ATR)
- CHGG 0.11
- ATOS 0.06
- MACD
- CHGG 0.01
- ATOS -0.00
- Stochastic Oscillator
- CHGG 10.53
- ATOS 45.83
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.